429 related articles for article (PubMed ID: 12093680)
1. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
Prince HE; Leber AL
Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
3. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
4. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
5. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
[TBL] [Abstract][Full Text] [Related]
6. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
7. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women.
Grangeot-Keros L; Mayaux MJ; Lebon P; Freymuth F; Eugene G; Stricker R; Dussaix E
J Infect Dis; 1997 Apr; 175(4):944-6. PubMed ID: 9086155
[TBL] [Abstract][Full Text] [Related]
8. The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants.
Vilibić-Cavlek T; Ljubin-Sternak S; Vojnović G; Sviben M; Mlinarić-Galinović G
Coll Antropol; 2012 Mar; 36(1):297-300. PubMed ID: 22816235
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
10. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
12. Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.
Seo S; Cho Y; Park J
Korean J Lab Med; 2009 Dec; 29(6):557-62. PubMed ID: 20046088
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the LIAISON(®) CMV IgG Avidity II and the VIDAS(®) CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women.
Sellier Y; Guilleminot T; Ville Y; Leruez-Ville M
J Clin Virol; 2015 Nov; 72():46-8. PubMed ID: 26397203
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection.
de Souza S; Bonon SH; Costa SC; Rossi CL
Rev Inst Med Trop Sao Paulo; 2003; 45(6):323-6. PubMed ID: 14762632
[TBL] [Abstract][Full Text] [Related]
15. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.
Prince HE; Lapé-Nixon M; Novak-Weekley SM
Clin Vaccine Immunol; 2014 Jun; 21(6):808-12. PubMed ID: 24671557
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
17. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing.
Kamel N; Metwally L; Gomaa N; Sayed Ahmed WA; Lotfi M; Younis S
Med Princ Pract; 2014; 23(1):29-33. PubMed ID: 24052007
[TBL] [Abstract][Full Text] [Related]
18. Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection.
Tanimura K; Tairaku S; Morioka I; Ozaki K; Nagamata S; Morizane M; Deguchi M; Ebina Y; Minematsu T; Yamada H
Clin Infect Dis; 2017 Oct; 65(10):1652-1658. PubMed ID: 29020153
[TBL] [Abstract][Full Text] [Related]
19. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.
Lumley S; Patel M; Griffiths PD
J Med Virol; 2014 May; 86(5):834-7. PubMed ID: 24395084
[TBL] [Abstract][Full Text] [Related]
20. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women.
Macé M; Sissoeff L; Rudent A; Grangeot-Keros L
Prenat Diagn; 2004 Nov; 24(11):861-3. PubMed ID: 15565653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
